A Phase 4 interventional study of Adductor-Canal-Blockade with Ropivacaine and Adductor-Canal-blockade with saline in Postoperative Pain and Knee Arthroplasty, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 40 Years to 85 Years. Per ClinicalTrials.gov, last updated 2013-08-22.
Sponsored by Rigshospitalet, Denmark · Phase 4, Interventional, and Treatment
The purpose of this study is to determine whether Adductor-Canal-Blockade is effective at reducing pain and morphine consumption after revision knee arthroplasty.
5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.
This study's enrollment of 36 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.
Browse Pain, Postoperative studies →Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Adductor-Canal-Blockade with Ropivacaine
Procedure: Adductor-Canal-blockade with saline
US-guided Adductor-Canal-Blockade with ropivacaine 7,5 mg/ml
Also known as: Naropine, Postoperative pain, US-guided nerve block
US-guided Adductor-Canal-blockade with saline
Also known as: Placebo block
Pain during 45 degrees active flexion of the knee
0-100 mm at a visual analogue scale (VAS), at 4 hours postoperative.
Time frame: 4 hours postoperative
Pain during 45 degrees active flexion of the knee
0-100 mm at a visual analogue scale (VAS), registered at the intervals 1, 2, 4, 6 and 8 hours postoperative, calculated as "the area under the curve" (AUC) for the interval 1-8 hours postoperative.
Time frame: 1-8 hours postoperative
Pain during 45 degrees active flexion of the knee
0-100 mm at a visual analogue scale (VAS), at 24 hours postoperative.
Time frame: 24 hours postoperative
Pain during rest
0-100 mm at a visual analogue scale (VAS), registered at the intervals 1, 2, 4, 6 and 8 hours postoperative, calculated as "the area under the curve" (AUC) for the interval 1-8 hours postoperative.
Time frame: 1-8 hours postoperative
Pain during rest
0-100 mm at a visual analogue scale (VAS), at 24 hours postoperative.
Time frame: 24 hours postoperative
Total morphine consumption
Total morphine consumption at the intervals 0-8, 8-24 and 0-24 hours postoperative.
Time frame: 0-24 hours postoperative
Postoperative nausea
Nausea scores(0-3)registered at 1,2,4,6 and 8 hours postoperative, calculated as mean value for the interval 1-8 hours postoperative.
Time frame: 1-8 hours postoperative
Postoperative nausea
Nausea score(0-3)at 24 hours postoperative.
Time frame: 24 hours postoperative
Postoperative vomiting
Number of vomiting episodes at the intervals 0-8, 8-24 and 0-24 hours postoperative.
Time frame: 0-24 hours postoperative
Zofran consumption
Total zofran consumption at the intervals 0-8, 8-24 and 0-24 hours postoperative.
Time frame: 0-24 hours postoperative
Sedation
Sedation score (0-3) registered at 1,2,4,6 and 8 hours postoperative, calculated as the mean value for the interval 1-8 hours postoperative.
Time frame: 1-8 hours postoperative
Sedation
Sedation score (0-3) at 24 hours postoperative.
Time frame: 24 hours postoperative
This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rigshospitalet, Denmark